Intro

This chapter examines the changing standards for diagnosing relapsing multiple sclerosis, particularly the diminishing emphasis on the requirement for dissemination in time. It discusses the integration of advanced MRI technology and cerebrospinal fluid analysis, highlighting recent findings that could facilitate a more efficient diagnostic process for patients.